So, let's say that JNJ is a major venture investor in Titan. Implementing the Shareholder Rights Plan makes sense to avoid a hostile takeover. There would be no rush fir JNJ to purchase because they may be a major stock holder. They would wait for clinical trials and FDA submission or approval. The purchase price per share of $20, $30, $40, would be significantly offset due to their venture investment. Basically paying for all shares that they don't own. This totally makes sense to me. What are your thoughts?
News 
Market Data 
Discover 
